首页 | 本学科首页   官方微博 | 高级检索  
     

4组治疗消化性溃疡方案的成本-效果分析
引用本文:杨素萍,杨理会,李小鸿. 4组治疗消化性溃疡方案的成本-效果分析[J]. 中国临床药学杂志, 2002, 11(5): 281-283
作者姓名:杨素萍  杨理会  李小鸿
作者单位:浙江省乐清市人民医院药剂科,乐清,325600
摘    要:
目的:探讨不同的药物治疗方案对幽门螺杆菌(HP)感染的消化性溃疡疾病的成本-效果。方法:运用药物经济学成本-效果分析法对4组治疗方案即A组:奥美拉唑+阿莫西林+甲硝唑;B组:兰索拉唑+阿莫西林+甲硝唑;C组:奥美拉唑+克拉霉素+甲硝唑;D组:兰索拉唑+丽珠胃三联(枸橼酸铋钾-克拉霉素-替硝唑)进行分析评价。结果:4组方案的成本-效果比(C/E),HE消除:A9.08,B8.56,C12.05,D12.97;溃疡治愈:A8.62,B8.23,C11.44,D13.65。结论:B组为最佳治疗方案,值得推广应用。

关 键 词:消化性溃疡 治疗方案 成本-效果分析 奥美拉唑 阿莫西林 甲硝唑 兰索拉唑 克拉霉素 丽珠胃三联
文章编号:1007-4406(2002)05-0281-03

Cost-effectiveness analysis in 4 groups of the therapeutic schemes for peptic ulcer
Yang Shuping,Yang Lihui,Li Xiaohong. Cost-effectiveness analysis in 4 groups of the therapeutic schemes for peptic ulcer[J]. Chinese Journal of Clinical Pharmacy, 2002, 11(5): 281-283
Authors:Yang Shuping  Yang Lihui  Li Xiaohong
Abstract:
AIM: To explore the cost effectiveness of the various drug treatment schemes in peptic ulcer of HP infection. METHODS: Four groups treatment schemes (group A: omeprazole amoxicillin metronidazole; group B: lansoprazole amoxicillin metronidazole, group C: omeprazole clarithromycin metronidazole, group D: lansoprazole Li Zhu three stomachic drug unite) were evaluated by means of the cost effectiveness analytic methods of drug economics. RESULTS: The cost effectiveness ratio for 4 groups was HP eraduation: A 9.08, B 8.56, C 12.05, D 12.97; ulcer healing: A 8.62, B 8 23, C 11.44, D 13.65. CONCLUSION: The best treatment scheme is group B, and may be worth spreading application.
Keywords:peptic ulcer  treatment scheme  cost effectiveness analysis
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号